NCT05873543 The Effect of a Smartphone-assisted Hybrid Cardiac Rehabilitation Program in Patients With Heart Failure.
| NCT ID | NCT05873543 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-01-26 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-01-26 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled trial is to compare the impact of a case manager-led smartphone-assisted hybrid cardiac rehabilitation program with usual care in patients with HF. Participants will undergo a 12-week program led by a case manager and assisted by a smartphone. The study aims to answer two main questions: 1. Is the novel cardiac rehabilitation model feasible for patients with HF? 2. Does the intervention group show a significant improvement in exercise capacity and adherence compared to the usual care group?
Eligibility Criteria
Inclusion Criteria: * Patients with heart failure between the ages of 18 and 80 years old. * NYHA (New York Heart Association) functional classification of 1 to 3. * Patients must be in a stable condition and under outpatient follow-up. Exclusion Criteria: * Patients who have contraindications for exercise according to the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription. * Patients who are unable to complete cardiopulmonary exercise testing. * Patients who are unable to follow verbal instructions. * Patients who are unable to walk independently or pedal a stationary bicycle. * Patients who are unable to use communication app on a smartphone. * Patients who already engage in physical activity exceeding the recommended moderate intensity of 150 minutes per week or are currently participating in cardiac rehabilitation. * Patients who do not provide consent to participate in the trial.
Contact & Investigator
Hung-Jui Chuang, MD
PRINCIPAL INVESTIGATOR
Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT05873543 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05873543 currently recruiting?
Yes, NCT05873543 is actively recruiting participants. Contact the research team at rexintwo@gmail.com for enrollment information.
Where is the NCT05873543 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05873543 clinical trial?
NCT05873543 is sponsored by National Taiwan University Hospital. The principal investigator is Hung-Jui Chuang, MD at Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.